Yonseisarangmoa women disease hospital
Yonseisarangmoa women disease hospital
Republic of Korea, Seoul
Go Mi Hyang
25 years of experience
Clinic is certified :
Artificial insemination in the Republic of Korea typically costs from AUD $1,289 to AUD $2,435. Total costs depend on the required hormonal medications, clinic tier, and specific diagnostic testing. In Australia, this procedure averages AUD $3,294, meaning patients save approximately 43%. Basic cycles usually include sperm preparation and the insemination procedure itself.
Bookimed Expert Insight: Korea offers high success rates through specialists like Dr. Hong Jung Lee. Choosing specialized women's hospitals over university centers provides significant savings without compromising security. Clinics like Yonseisarangmoa women disease hospital focus on adult-only care and minimally invasive precision. This specialized approach ensures tailored fertility protocols while avoiding the heavy surcharges found at major general hospitals.
| Republic of Korea | Thailand | Turkey | |
| Artificial Insemination | from AUD $1,217 | from AUD $1,719 | from AUD $1,103 |
No hidden fees – just official clinic prices. Pay at the clinic for Artificial Insemination upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Artificial Insemination and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Artificial Insemination journey.
Dr Go Mi Hyang is a dedicated specialist at Yonseisarangmoa hospital with formal residency training from Gachon University Gil Hospital.
Professor Hong Jung Lee is the Director of Yonsei Sarangmoa Women's Hospital and holds prestigious academic positions at two of South Korea's top medical schools.
Professor Hong Ju represents elite medical training from Yonsei University – one of the most prestigious medical institutions in South Korea.
Professor An Jea Hyeong is a highly regarded specialist in reproductive health and female medicine at Yonseisarangmoa Women's Hospital.
Artificial insemination in South Korea is a highly effective fertility option. Leading clinics like Yonseisarangmoa Women Disease Hospital use advanced laboratory washing and ultrasound monitoring. Specialists there have helped facilitate over 10,000 births. Their success rates compete with top Western medical centres.
Bookimed Expert Insight: South Korean specialists often use intensive medication protocols like growth hormones to help patients with low ovarian reserves. This approach can be more flexible than in Australia. It allows patients to achieve successful retrievals even after previous attempts elsewhere have failed.
Patient Consensus: Success rates for IUI in Korea match Western standards. Many find clinics more progressive with medications for difficult cases. Planning a longer stay for monitoring is essential for the best results.
Artificial insemination in South Korea involves placing concentrated sperm directly into the uterus. It typically uses Intrauterine Insemination (IUI). Specialists at clinics like Yonseisarangmoa women disease hospital combine precise follicle monitoring with medication. This improves success rates while prioritising patient safety.
Bookimed Expert Insight: While South Korea is famous for high-tech IVF, its IUI protocols are exceptionally refined. Yonseisarangmoa women disease hospital specialists like Dr Hong Jung Lee treat over 4,500 patients each year. This massive volume means Korean clinics have mastered "minimal stimulation" protocols. These achieve high success rates without the risk of ovarian hyperstimulation syndrome. This complication often occurs in less experienced centres.
Patient Consensus: Patients find the Korean approach very personalised and thorough. They frequently note how doctors suggest options like growth hormones. This happens if standard protocols do not work immediately. A 3-week stay in Seoul is often recommended. This allows complete monitoring of the cycle.
The standard artificial insemination protocol in Korea combines hormone stimulation, follicle monitoring, and intrauterine insemination (IUI). Specialist centres such as Yonseisarangmoa Women Disease Hospital include initial blood panels and diagnostic hormone tests. They also offer ultrasound monitoring and sperm washing. The washing isolates high-quality sperm before clinical insemination.
Bookimed Expert Insight: While IUI is affordable, Bookimed data shows some Korean clinics also offer more intensive options. These include IVF with gender selection. Specialists like Dr Hong Jung Lee at Yonseisarangmoa often combine artificial insemination and robotic surgery. This helps treat fibroids.
Patient Consensus: Expect to stay in Korea for about 5 weeks. This covers the full medication and monitoring cycle. Most couples appreciate how meticulously Korean specialists time the trigger shot. This gives the best results.
South Korea hosts world-leading fertility facilities, particularly in Seoul, specialising in advanced reproductive technology and high success rates. Reputable centres include CHA Fertility Centre, Maria Fertility Hospital, and Yonseisarangmoa Women Disease Hospital. It has supported over 10,000 successful births through its specialised care.
Bookimed Expert Insight: While Gangnam centres are famous, clinics such as Yonseisarangmoa provide award-winning international patient services with significant experience. Their clinicians often hold multiple adjunct professorships at top universities like Yonsei and Inje. This level of academic integration gives patients access to the latest stimulation protocols and cryopreservation techniques available in Korea.
Patient Consensus: Clinics in Korea offer progressive options like growth hormones that are rarely available in Western centres. Professional support for English speakers is excellent. Patients should plan a 3-month stay for full monitoring.